COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 95 filers reported holding COHERUS BIOSCIENCES INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $5,875,000 | -31.8% | 290,000 | -25.6% | 0.74% | -22.4% |
| Q2 2019 | $8,619,000 | +40.1% | 390,000 | -13.6% | 0.95% | +31.8% |
| Q1 2019 | $6,153,000 | +111.7% | 451,131 | +40.5% | 0.72% | +116.9% |
| Q4 2018 | $2,906,000 | -46.8% | 321,131 | -3.0% | 0.33% | -39.4% |
| Q3 2018 | $5,464,000 | +11.5% | 331,131 | -5.4% | 0.55% | +9.4% |
| Q2 2018 | $4,900,000 | +26.7% | 350,000 | 0.0% | 0.50% | +5.0% |
| Q1 2018 | $3,868,000 | +25.6% | 350,000 | 0.0% | 0.48% | +14.7% |
| Q4 2017 | $3,080,000 | +28.2% | 350,000 | +94.4% | 0.42% | +35.5% |
| Q3 2017 | $2,403,000 | -0.8% | 180,000 | +6.6% | 0.31% | -11.8% |
| Q2 2017 | $2,423,000 | +2.9% | 168,872 | +51.6% | 0.35% | -6.7% |
| Q1 2017 | $2,355,000 | -24.9% | 111,357 | 0.0% | 0.37% | -37.9% |
| Q4 2016 | $3,135,000 | -99.9% | 111,357 | -15.2% | 0.60% | +7.5% |
| Q3 2016 | $3,517,740,000 | +158428.2% | 131,357 | 0.0% | 0.56% | +41.9% |
| Q2 2016 | $2,219,000 | – | 131,357 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |